"Safety & Efficacy of Cyclophosphamide plus Total Body Irradiation with Post-Transplant Cyclophosphamide for Allogeneic Hematopoietic Stem Cell Transplantation"

"Predictability of Methicillin-Resistant Staphylococcus Aureus Nasal Swabs in Adult and Pediatric Oncology"

 

Speakers: 

Ryan Lozano, PharmD, PGY2 Hematology/Oncology Pharmacy Resident - has nothing to disclose.

Dominick Patafio, PharmD, PGY2 Hematology/Oncology Pharmacy Resident - has nothing to disclose.

Moderator: 

Tristan Maiers, PharmD, BCOP, PGY2 Oncology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

  • Review the background of allogeneic stem cell transplants
  • Describe the purpose and methods used in the transplant study
  • Discuss study results and implications of the transplant study
  • Describe the current literature surrounding the clinical utility of the MRSA nasal swab
  • Determine the negative predictive value of the MRSA nasal swab in oncology patients with febrile neutropenia

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Tristan Maiers, PharmD, BCOP; Rajiv Panikkar, MD; Michele Long, BSN; Jaime Weeder, NP and Christopher Kashi, PA-C have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None

Session date: 
05/06/2025 - 12:00pm to 1:00pm EDT
Location: 
Geisinger Medical Center and Virtual via Teams
100 North Academy Avenue
Knapper Clinic
Danville, PA 17822
United States
  • 1.00 AAPA Category I CME
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ANCC
  • 1.00 Participation Credit
Please login or register to take this course.